Methods: Colonic and small-bowel MФ from wildtype (WT), IL-10knockout (IL-10KO) and germ-free (GF) mice were analysed by flow cytometry/qPCR.
Results: Proportions of total MФ were enhanced in the colon compared to the small-bowel. Mature (MHC Class II+/Ly6C-) MФ expressed less ALDH1A2/ALDH1A3 in the colon, but colonic MФ favoured TGFβ/IL-1β expression. Colonic, but not small-bowel mature MФ showed decreased expression of TGFβ and ALDH1A2 in IL-10KO mice. Furthermore, inflammatory intermediary (MHC Class II+/Ly6C+) MФ accumulated in the colon, but not the small-bowel of IL-10KO mice. MФ in GF mice were predominantly mature MФ, with very few monocytes/intermediary MФ. These mature MФ in GF mice exhibited enhanced expression of cytokines IL-23/IL-6/TNFα and increased expression of the aryl-hydrocarbon receptor (for recognition of environmental antigens), alongside decreased expression of IL-10 and ALDH1A2. These differences were more striking in the small-bowel. MФ numbers in the MLN were increased in IL-10KO and GF mice, suggesting that IL-10 as well the microbiota may act to limit MФ migration from the intestine in the steady-state.
Conclusions: These data provide an important role for IL-10 in MФ-mediated immune tolerance in the colon in particular, and for the gut microbiota in MФ-mediated immune tolerance in the small-bowel. We are currently identifying the role of the microbiota in synergizing with IL-10 to regulate MФ homeostasis in the intestine.